|

ICI Clinical Trials

2 actively recruiting trials

Also known as: Immune checkpoint inhibitors

Pipeline

Phase 1: 1

Top Sponsors

  • UMC Utrecht1
  • Guangzhou University of Traditional Chinese Medicine1

Indications

  • Cancer2
  • Metastatic Cancer1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other2 trials

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients
N/A
Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.